文献速递母胎医学

印度单基因病产前诊断的趋势与挑战——中低收入国家背景下超过五年的研究

Investigating Trends and Challenges in Prenatal Diagnosis of Monogenic Conditions in India-An LMIC Setting-Over Half a Decade.
PubMed 文献 · Prenat Diagn · 2025-05-19

该研究回顾性分析印度南部一家围产中心2018年1月至2022年12月间因单基因病接受侵入性胎儿检测的孕妇数据。1460例中704例(48.2%)为单基因病检测,靶向检测636例(90.3%)、扩展检测68例(9.6%);血红蛋白病最常见(331例,47%),神经发育疾病(78例,11.1%)和先天代谢缺陷(76例,10.8%)近年呈上升趋势(p<0.001)。

要点

  • 单基因病是产前侵入性检测的主要指征,靶向检测显著多于扩展检测。
  • 血红蛋白病仍是最常见指征,但神经发育疾病和先天代谢缺陷呈上升趋势。
  • 扩展检测中全外显子测序使用逐年增加,超过临床外显子测序。

核心结论

  • 单基因病是产前侵入性检测的主要指征,靶向检测显著多于扩展检测。
  • 血红蛋白病仍是最常见指征,其他指征近年呈上升趋势;扩展检测中全外显子测序使用日益增多。

研究设计与样本

  • 回顾性分析2018年1月至2022年12月印度南部一家围产中心因单基因病接受侵入性产前诊断的孕妇数据。

主要发现

  • 1460例孕妇中704例(48.2%)因单基因病接受侵入性检测。
  • 靶向检测636例(90.3%),扩展检测68例(9.6%),五年间靶向与扩展检测比例恒定为9:1。
  • 血红蛋白病为最常见指征(331例,47%),神经发育疾病(78例,11.1%)和先天代谢缺陷(76例,10.8%)近年呈上升趋势(p<0.001)。
  • 研究期间因单基因病接受产前诊断的孕妇数量显著增加(p=0.003)。
  • 全外显子测序使用(39例,57%)较临床外显子测序(27例,40%)显著增加(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To study the overall trends, indications, timing, mode of testing, geographical distribution of cases and challenges in prenatal diagnosis (PND) of single gene conditions using invasive fetal testing in India over half a decade. We also studied the clinical indications of pregnant women undergoing targeted and expanded testing. METHODS: This is a retrospective analysis of data of pregnant women who underwent an invasive procedure for diagnosis of single gene conditions at a perinatal care center in South India between January 2018 and December 2022. RESULTS: Total 704 out of 1460 (48.2%) pregnant women underwent invasive testing for single gene conditions. Targeted testing was carried out in 636 cases (90.3%), while expanded testing comprised 68 cases (9.6%). The ratio of women undergoing targeted testing versus expanded testing was constant at 9:1 across the five years. While hemoglobinopathies (n = 331, 47%) continued to be the most common indication for testing, other indications such as neurodevelopmental conditions (n = 78, 11.1%) and inborn errors of metabolism (n = 76, 10.8%) have shown a rising trend in the recent years (p < 0.001). The number of women undergoing PND for single gene conditions has risen significantly across the study period (p = 0.003). Over the years, there was also a significant rise in the use of whole exome sequencing (n = 39, 57%) over clinical exome sequencing (n = 27, 40%) (p < 0.001). CONCLUSIONS: Single gene conditions were major indications for prenatal invasive testing. Targeted testing was performed significantly more frequently than expanded testing. Although hemoglobinopathy continues to be the most common indication, others showed a rising trend in the recent years. For expanded testing, WES has been increasingly used over CES, especially in the recent years.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. James LS, Luke ND, Sindhuvi E, et al. Investigating Trends and Challenges in Prenatal Diagnosis of Monogenic Conditions in India-An LMIC Setting-Over Half a Decade. Prenat Diagn. 2025. PMID: 40387182. doi:10.1002/pd.6815

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。